Patents by Inventor Bhavesh Govind

Bhavesh Govind has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunoassay for SARS-CoV-2 antibodies
    Patent number: 11703507
    Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the strain of coronavirus that causes coronavirus disease 2019 (COVID-19), the respiratory illness responsible for the COVID-19 pandemic. Antibodies produced from an immune response against SARS-CoV-2 infection are used to analyze prior exposure to the virus. The present invention provides methods for detecting antibodies in response to SARS-CoV-2 infection in a single multiplex immunoassay.
    Type: Grant
    Filed: August 6, 2021
    Date of Patent: July 18, 2023
    Assignee: Pictor Limited
    Inventors: Sandeep Kumar Vashist, Lionel Gilles Guiffo Djoko, Bhavesh Govind
  • IMMUNOASSAY FOR SARS-CoV-2 ANTIBODIES
    Publication number: 20220163528
    Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the strain of coronavirus that causes coronavirus disease 2019 (COVID-19), the respiratory illness responsible for the COVID-19 pandemic. Antibodies produced from an immune response against SARS-CoV-2 infection are used to analyze prior exposure to the virus. The present invention provides methods for detecting antibodies in response to SARS-CoV-2 infection in a single multiplex immunoassay.
    Type: Application
    Filed: July 29, 2021
    Publication date: May 26, 2022
    Inventors: Sandeep Kumar Vashist, Lionel Gilles Guiffo Djoko Gilles, Bhavesh Govind
  • IMMUNOASSAY FOR SARS-CoV-2 ANTIBODIES
    Publication number: 20220034904
    Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the strain of coronavirus that causes coronavirus disease 2019 (COVID-19), the respiratory illness responsible for the COVID-19 pandemic. Antibodies produced from an immune response against SARS-CoV-2 infection are used to analyze prior exposure to the virus. The present invention provides methods for detecting antibodies in response to SARS-CoV-2 infection in a single multiplex immunoassay.
    Type: Application
    Filed: September 7, 2021
    Publication date: February 3, 2022
    Inventors: Sandeep Kumar Vashist, Lionel Gilles Guiffo Djoko, Bhavesh Govind, Richard Janeczko
  • IMMUNOASSAY FOR SARS-CoV-2 ANTIGEN AND ANTIBODIES
    Publication number: 20220034886
    Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the strain of coronavirus that causes coronavirus disease 2019 (COVID-19), the respiratory illness responsible for the COVID-19 pandemic. Antibodies produced from an immune response against SARS-CoV-2 infection are used to analyze prior exposure to the virus. The present invention provides methods for detecting antibodies in response to SARS-CoV-2 infection in a single multiplex immunoassay.
    Type: Application
    Filed: August 6, 2021
    Publication date: February 3, 2022
    Inventors: Sandeep Kumar Vashist, Lionel Gilles Guiffo Djoko, Bhavesh Govind